Your session is about to expire
← Back to Search
Behavioural Intervention
Osteopathic Manipulative Treatment for Arrhythmia
N/A
Waitlist Available
Led By Todd Cohen, MD
Research Sponsored by New York Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month from enrollment.
Awards & highlights
Study Summary
This trial will focus on patients who have already been diagnosed with an arrhythmia, and will use measurements from their implanted devices to quantify changes in the number of cardiac events experienced.
Eligible Conditions
- Arrhythmia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month from enrollment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month from enrollment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decrease in Cardiac Events
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Osteopathic Manipulative TreatmentExperimental Treatment1 Intervention
Group A will receive osteopathic treatment by NMM/OMM board certified attending physicians. The protocol for the OMT intervention group is based on the guidelines set forth previously in textbooks. The protocol will last 25 minutes total, with 10 minutes for the evaluation and 15 minutes for treatment. The protocol will start in ribs so as to not exacerbate any tachyarrhythmias with rib raising, thoracic myofascial release, and a pectoralis lift. The investigator will then proceed with opening the thoracic inlet, cervical myofascial release, suboccipital release, and then end by checking for and treating Chapman's points. The physician will submit their osteopathic evaluation and fill out a form in order to determine if certain arrhythmias have an associated trigger point.
Group II: Light Touch TreatmentPlacebo Group1 Intervention
Group B will receive a light touch treatment, based on previous research done studying heart rate variability and OMM, where sham treatment was utilized. The protocol consisted of contacting the right ankle, left knee, right hip, diaphragm, right shoulder, neck, and cranium for precisely two minutes each, with the goal of preventing placebo autonomic nervous system stimulation. The protocol is 25 minutes long, with 10 minutes for the evaluation and 15 minutes for treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Osteopathic Manipulative Treatment
2008
Completed Phase 4
~2530
Find a Location
Who is running the clinical trial?
New York Institute of TechnologyLead Sponsor
51 Previous Clinical Trials
2,029 Total Patients Enrolled
Todd Cohen, MDPrincipal InvestigatorNew York Institute of Technology College of Osteopathic Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants still able to enlist in this trial?
"Affirmative, the clinicaltrials.gov website reports that this research is still open to participants; with its launch date set on June 4th 2019 and latest update being November 1st 2021. There are 40 spots available at a single medical facility."
Answered by AI
What is the current size of this medical research experiment?
"Indeed, based on the information provided by clinicaltrials.gov, this trial is currently recruiting patients - it was first posted in June 2019 and updated as recently as November 2021. At present time, a total of 40 individuals are needed to join the study at one location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger